drugset / Trial / NCT05054400

Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR

NCT05054400 ↗

Phase 0 Withdrawn M.D. Anderson Cancer Center
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the relationship between brain malignancy volume as defined by post-contrast T1 weighted and F18 Fluciclovine before and following LITT. We hypothesize that imaging with F18 Fluciclovine will be superior to anatomic MR imaging in lesion volume assessment before treatment and that residual F18 Fluciclovine defined tumor will predict local post-LITT disease recurrence.

Timeline

Start
2020-02-05
Primary completion
2023-08-29
Completion
2023-08-29

Outcome

Outcome not reported

Stopped (Enrollment): “0 participant accrual”

Drugs

EvaluationDrugModalityDoseRoute
Subject F18 Fluciclovine Diagnostic / imaging agent — Intravenous